Jason Patrick Meyenburg

Insider Reports History

Location: Rockville, MD
Signature: /s/ Brian Piekos, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Patrick Meyenburg:

Form 4 holding Chief Executive Officer, Director

Gemini Therapeutics, Inc. /DE

Security class: Restricted Stock Units
Shares / value: 123,600
Estimated value
Report date: 03 Jan 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Jason Patrick Meyenburg

4 IRON

Gemini Therapeutics, Inc. /DE

Report period: 03 Jan 2022
Transactions: 1
Transaction value: $0
Filing time: 05 Jan 2022, 15:08
Role: Chief Executive Officer, Director
Next action: Open filing details

4 IRON

Gemini Therapeutics, Inc. /DE

Report period: 14 May 2021
Transactions: 1
Transaction value: +$122,929
Filing time: 18 May 2021, 16:45
Role: President & CEO, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .